Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Clinical pharmacokinetics of nicotine after oral, i.v. and rectal administration

June 11, 1997

Chugai MSD to market OTC famotidine in Japan

June 10, 1997

Target enrollment reached in phase III trial of Interferon's Alferon N Injection

June 6, 1997

LXR refocuses Lexirin development

June 6, 1997

Schering-Plough Research Institute reveals structure of enzyme in HCV life cycle

June 6, 1997

U.S. patent covers use of Synsorb Cd in C. difficile-associated diarrhea

June 5, 1997

Axcan acquires U.S. rights to Viokase

June 5, 1997

Proarrhythmia associated with cisapride; exacerbation by cytochrome P-450 inhibitors

June 3, 1997

Janssen characterizes new enterokinetic agent

May 30, 1997

New immunomodulator from Orion with potential in IBD

May 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...